Discontinued — last reported Q4 '22
Idexx Laboratories Interest Income increased by 1.7% to $597.00K in Q1 2026 compared to the prior quarter. Year-over-year, this metric declined by 50.9%, from $1.22M to $597.00K. Over 4 years (FY 2021 to FY 2025), Interest Income shows an upward trend with a 62.3% CAGR. This decline may warrant attention — for this metric, higher values are generally preferred.
Higher interest income suggests a strong cash position or a favorable interest rate environment for the company's investments.
Interest income is the revenue earned from cash deposits, marketable securities, and other interest-bearing investments....
Varies based on cash management strategies; companies with large cash piles will report higher interest income than those with high debt.
interest_income| Q2 '21 | Q3 '21 | Q4 '21 | Q1 '22 | Q2 '22 | Q3 '22 | Q4 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | Q1 '26 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $91.00K | $122.00K | $169.00K | $143.00K | $334.00K | $353.00K | $235.00K | $416.00K | $327.00K | $1.26M | $3.63M | $4.43M | $3.35M | $2.71M | $2.20M | $1.22M | $627.00K | $580.00K | $587.00K | $597.00K |
| QoQ Change | — | +34.1% | +38.5% | -15.4% | +133.6% | +5.7% | -33.4% | +77.0% | -21.4% | +283.8% | +189.3% | +22.1% | -24.3% | -19.1% | -19.0% | -44.7% | -48.4% | -7.5% | +1.2% | +1.7% |
| YoY Change | — | — | — | — | +267.0% | +189.3% | +39.1% | +190.9% | -2.1% | +255.5% | >999% | +965.4% | +925.7% | +116.3% | -39.4% | -72.6% | -81.3% | -78.6% | -73.3% | -50.9% |